HCV | Hepatitis C virus |
CHC | Chronic hepatitis C |
HCC | Hepatocellular carcinoma |
DAAs | Direct-acting antivirals |
RAS | Resistance-associated substitution |
HCV | Hepatitis C virus |
CHC | Chronic hepatitis C |
HCC | Hepatocellular carcinoma |
DAAs | Direct-acting antivirals |
RAS | Resistance-associated substitution |